Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | --1.23B | 8.66%1.94B | -12.76%1.46B | 2,421.85%640.9M | 111,558.75%1.79B | --1.68B | --25.41M | --1.6M |
| Operating income | 1.23B | 8.66%1.94B | -12.76%1.46B | 2,421.85%640.9M | 111,558.75%1.79B | 1.68B | 25.41M | 1.6M |
| Cost of sales | ---639.53M | -170.45%-1.16B | -147.55%-802.46M | -1,718.72%-179.34M | ---427.66M | ---324.16M | ---9.86M | ---- |
| Operating expenses | -639.53M | -170.45%-1.16B | -147.55%-802.46M | -1,718.72%-179.34M | -427.66M | -324.16M | -9.86M | |
| Gross profit | 589.4M | -42.26%784.67M | -51.21%659.55M | 2,867.65%461.56M | 84,830.31%1.36B | 1.35B | 15.55M | 1.6M |
| Administrative expenses | ---125.55M | -153.64%-158.69M | -189.58%-126.84M | -197.49%-55.2M | -96.01%-62.57M | ---43.8M | ---18.55M | ---31.92M |
| Research and development expenses | ---349.39M | -49.68%-836.73M | -61.64%-601.93M | -168.21%-311.09M | -64.46%-559M | ---372.39M | ---115.99M | ---339.89M |
| Special items of operating profit | ---7.44M | -50.59%21.76M | -109.62%-3.95M | -40.27%976K | 2,604.79%44.03M | --41.06M | --1.63M | --1.63M |
| Operating profit | 107.03M | -124.19%-188.99M | -107.49%-73.17M | 182.01%96.24M | 311.99%781.36M | 976.62M | -117.36M | -368.58M |
| Financing income | --39.47M | 39.52%48.11M | 60.63%38.81M | 480.16%13.33M | 955.17%34.48M | --24.16M | --2.3M | --3.27M |
| Financing cost | ---573K | -32.98%-250K | -30.34%-189K | -22.22%-66K | -150.67%-188K | ---145K | ---54K | ---75K |
| Special items of earning before tax | ---2.22B | 14.19%-873.42M | 47.73%-501.35M | 76.83%-156.97M | -4,590.78%-1.02B | ---959.2M | ---677.55M | ---21.7M |
| Earning before tax | -2.07B | -401.63%-1.01B | -1,393.32%-535.9M | 94.01%-47.46M | 47.75%-202.25M | 41.44M | -792.66M | -387.09M |
| Tax | ---- | 76.89%-35.89M | 80.30%-30.58M | ---18.48M | ---155.26M | ---155.26M | ---- | ---- |
| After-tax profit from continuing operations | -2.07B | -193.82%-1.05B | -397.67%-566.48M | 91.68%-65.94M | 7.64%-357.51M | -113.83M | -792.66M | -387.09M |
| Earning after tax | -2.07B | -193.82%-1.05B | -397.67%-566.48M | 91.68%-65.94M | 7.64%-357.51M | -113.83M | -792.66M | -387.09M |
| Profit attributable to shareholders | -2.07B | -193.82%-1.05B | -397.67%-566.48M | 91.68%-65.94M | 7.64%-357.51M | -113.83M | -792.66M | -387.09M |
| Basic earnings per share | -49.7 | -193.74%-131.3 | -398.59%-70.8 | 91.73%-8.2 | 7.64%-44.7 | -14.2 | -99.1 | -48.4 |
| Diluted earnings per share | -49.7 | -193.74%-131.3 | -398.59%-70.8 | 91.73%-8.2 | 7.64%-44.7 | -14.2 | -99.1 | -48.4 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.